Kalaris Therapeutics, Inc. (KLRS)
NASDAQ: KLRS · Real-Time Price · USD
4.320
+0.020 (0.47%)
Jun 26, 2026, 4:00 PM EDT - Market closed
Kalaris Therapeutics Stock Forecast
Stock Price Forecast
The 5 analysts with 12-month price forecasts for Kalaris Therapeutics stock have an average target of 16.4, with a low estimate of 7.00 and a high estimate of 25. The average target predicts an increase of 279.63% from the current stock price of 4.32.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Kalaris Therapeutics stock from 9 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 | Jun '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 4 | 4 | 4 | 4 | 5 | 6 |
| Buy | 1 | 1 | 1 | 2 | 2 | 2 |
| Hold | 1 | 1 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 6 | 6 | 6 | 7 | 8 | 9 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| TD Cowen | TD Cowen | Buy Initiates n/a | Buy | Initiates | n/a | n/a | Jun 15, 2026 |
| Wedbush | Wedbush | Buy Maintains $17 | Buy | Maintains | $17 | +293.52% | Jun 1, 2026 |
| Morgan Stanley | Morgan Stanley | Buy Maintains $14 | Buy | Maintains | $14 | +224.07% | May 13, 2026 |
| Citizens JMP | Citizens JMP | Buy Maintains $26 → $25 | Buy | Maintains | $26 → $25 | +478.70% | May 13, 2026 |
| William Blair | William Blair | Buy Maintains n/a | Buy | Maintains | n/a | n/a | May 12, 2026 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
11.43M
EPS This Year
-2.03
from -2.85
EPS Next Year
-1.63
from -2.03
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | n/a | 80.0M | |
| Avg | n/a | 11.4M | |
| Low | n/a | n/a |
Revenue Growth
| Revenue Growth | 2027 | 2028 |
|---|---|---|
| High | - | -100.0% |
| Avg | - | -100.0% |
| Low | - | -100.0% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | -1.62 | 0.65 | |
| Avg | -2.03 | -1.63 | |
| Low | -2.19 | -2.21 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | - | |
| Avg | - | - | |
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.